Non-alcoholic fatty liver disease is a very common medical condition, driven by a
combination of genetic and lifestyle factors, ultimately producing a severe chronic liver …

Heart failure (HF) and liver disease often co-exist. This is because systemic disorders and
diseases affect both organs (alcohol abuse, drugs, inflammation, autoimmunity, infections) …

Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

Coronary heart disease is an important source of mortality and morbidity among kidney
transplantation and liver transplantation candidates and recipients and is driven by …

Nonalcoholic steatohepatitis (NASH)-related cirrhosis has become one of the most common
indications for liver transplantation (LT), particularly in candidates older than 65 years …

In the changing landscape of liver transplantation (LT), we are now evaluating older and
sicker patients with more cardiovascular comorbidities, and the spectrum of cardiovascular …

Breakthroughs in hepatitis C virus (HCV) treatment and rising rates of intravenous drug use
have led to an increase in the number of organ donors who are HCV antibody–positive but …

Aims There has been significant evolution in operative and post-transplant therapies
following liver transplantation (LT). We sought to study their impact on cardiovascular (CV) …

Nonalcoholic fatty liver disease (NAFLD) is a common and emerging liver disease in adults,
paralleling the epidemic of obesity and diabetes, and leading to worrisome events …

Summary Liver transplant (ation)(LT) is the most effective treatment for patients with
decompensated liver disease. The increasing prevalence of obesity and type 2 diabetes and …